Abstract
OBJECTIVE:: The aim was to determine the survival of patients with advanced, unresectable pancreatic cancer in relation to whether they underwent nonsurgical biopsy of their primary tumor. METHODS:: A total of 1481 patients with distant stage pancreatic cancer diagnosed between 1992 and 2001 who underwent radiation treatment but not cancer-directed surgery were analyzed. The design is a retrospective cohort study from the Surveillance, Epidemiology, and End Results program of the US National Cancer Institute. Survival curves were created using Kaplan-Meier method and compared via log-rank test. RESULTS:: Of 1481 patients (median age, 66 years) included in our analysis, 1406 (95%) underwent nonsurgical biopsy (95%) and 75 (5%) did not. There was no statistically significant difference in overall median survival according to receipt of nonsurgical biopsy (Kaplan-Meier curve, log-rank test = 0.09). A subgroup analysis of patients younger than 65 years who did not undergo biopsy revealed a hazard ratio of 1.76 (95% confidence interval, 1.14-2.72); that is, there was a 76% higher hazard for death among younger patients who did not undergo biopsy compared with those who did (P = 0.011). CONCLUSION:: Nonsurgical biopsy did not seem to negatively impact survival among patients with advanced pancreatic cancer.
Original language | English (US) |
---|---|
Pages (from-to) | 289-292 |
Number of pages | 4 |
Journal | Pancreas |
Volume | 38 |
Issue number | 3 |
DOIs | |
State | Published - Apr 2009 |
Externally published | Yes |
Keywords
- Biopsy
- Endoscopic retrograde cholangiopancreatography
- Endoscopic ultrasound
- Pancreatic cancer
- Survival
ASJC Scopus subject areas
- Internal Medicine
- Endocrinology, Diabetes and Metabolism
- Hepatology
- Endocrinology